Movement Disorders in Chronic Kidney Disease - A Descriptive Review

J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105408. doi: 10.1016/j.jstrokecerebrovasdis.2020.105408. Epub 2020 Nov 1.

Abstract

Objectives: The objective of this study is to describe the mechanism of damage to subcortical structures in chronic kidney disease (CKD) and to describe the range of movement disorders associated with CKD.

Materials and methods: We have reviewed the Medline literature up to January of 2020 using key words movement disorders and chronic kidney disease. The reviewed articles were studied for mechanisms of subcortical damage in CKD as well as type of the reported movements, their frequency and updated treatment.

Results: The search revealed 183 articles most of them dealing with restless legs syndrome. The damage to basal ganglia in CKD resulted from several mechanisms including accumulation of nitro tyrosine caused by reactive oxygen species and action of uremic toxins leading to endothelial damage and dysfunction of blood-brain barrier. Involuntary movements in CKD include restless legs syndrome (RLS), myoclonus, asterixis, dystonia, chorea, tremor, and Parkinsonism.

Conclusions: Chronic kidney disease can cause several abnormal involuntary movements via damaging basal ganglia and subcortical structures. The most common movement disorders in CKD are RLS, myoclonus and asterixis. Restless legs syndrome and myoclonus when severe, need and respond to treatment. Movement disorders in CKD improve with improvement of kidney function.

Keywords: Chorea; Chronic kidney disease; Dystonia; Movement disorders; Myoclonus; Restless legs syndrome.

Publication types

  • Review

MeSH terms

  • Anti-Dyskinesia Agents / therapeutic use
  • Basal Ganglia / drug effects
  • Basal Ganglia / pathology
  • Basal Ganglia / physiopathology*
  • Chorea / etiology
  • Chorea / physiopathology
  • Dyskinesias / etiology
  • Dyskinesias / physiopathology
  • Dystonia / etiology
  • Dystonia / physiopathology
  • Humans
  • Kidney / physiopathology*
  • Movement Disorders / diagnosis
  • Movement Disorders / drug therapy
  • Movement Disorders / etiology*
  • Movement Disorders / physiopathology
  • Movement* / drug effects
  • Myoclonus / etiology
  • Myoclonus / physiopathology
  • Prognosis
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / physiopathology
  • Renal Insufficiency, Chronic / therapy
  • Restless Legs Syndrome / etiology
  • Restless Legs Syndrome / physiopathology

Substances

  • Anti-Dyskinesia Agents